Rebecca Araujo

DocwireNews

This week on DocWire News, editors spoke with Dr. Raj Chakraborty, assistant professor of medicine at Columbia University Irving Medical Center, about promising research on <a href="https://www.docwirenews.com/docwire-pick/bispecific-t-cell-engagers-for-multiple-myeloma-with-dr-chakraborty/">bispecific T-cell engagers (BiTEs)</a> for treatment of multiple myeloma, and things to consider when selecting between BiTEs and chimeric antigen receptor (CAR) T cell therapy.https://www.docwirenews.com/docwire-pick/bispecific-t-cell-engagers-for-multiple-myeloma-with-dr-chakraborty/&ndash;A <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/one-in-four-patients-with-breast-cancer-experience-cognitive-impairment/">systematic review</a> of patients with breast cancer found that a quarter of patients experience cognitive impairment before initiating anticancer therapy. Some patients showed improvement after treatment (15%) or at one-year follow up (31%). Rates of cognitive decline appeared to vary by treatment, with higher prevalence of long-term impairment in patients who received chemotherapy.https://www.docwirenews.com/docwire-pick/hem-onc-picks/one-in-four-patients-with-breast-cancer-experience-cognitive-impairment/&ndash;Cancer, not vascular disease, is the leading cause of death among people with diabetes, according to <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/cancer-not-vascular-diseases-no-1-cause-of-death-in-patients-with-diabetes/">a U.K. study</a>. &ldquo;Improvements in risk factors such as smoking and blood pressure, along with progress in medical treatments have contributed to large falls in deaths from heart disease and stroke,&rdquo; explained lead study author Dr. Jonathan Pearson-Stuttard. &ldquo;In contrast, improvements in cancer death rates have been much more modest, with improvements in those with diabetes lagging behind the general population.&rdquo;https://www.docwirenews.com/docwire-pick/hem-onc-picks/cancer-not-vascular-diseases-no-1-cause-of-death-in-patients-with-diabetes/&ndash;In a <a href="https://www.docwirenews.com/hematology-oncology/how-do-herbs-and-supplements-interact-with-chemotherapy/">survey of patients</a> with breast or prostate cancer who recently received chemotherapy, researchers found that most patients (84%) use additional herbs and supplements, or other medications that may interact with their cancer treatment. More than 600 unique medication interactions occurred before, during, and after chemotherapy&mdash;most of which occurred during. &ldquo;Patients should be educated about the risk of herb and supplement&ndash;related medication interactions during treatment,&rdquo; the study authors recommended.https://www.docwirenews.com/hematology-oncology/how-do-herbs-and-supplements-interact-with-chemotherapy/

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Hem/Onc Roundup: Cancer is the Leading Cause of Death Among Patients with Diabetes in the UK, and More

Oncology

This week on DocWire News, editors spoke with Dr. Raj Chakraborty, assistant professor of medicine at Columbia University Irving Medical Center, about promising research on ...

Hem/Onc Roundup: Cancer is the Leading Cause of Death Among Patients with Diabetes in the UK, and

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe